Induction of Le(Y) antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells

被引:0
|
作者
Yamada, T
Ohwada, S
Saitoh, F
Adachi, M
Morishita, Y
Hozumi, M
机构
[1] GUNMA UNIV,SCH MED,DEPT SURG 2,MAEBASHI,GUMMA 371,JAPAN
[2] JAPAN IMMUNORES LAB CO LTD,TAKASAKI,GUMMA 370,JAPAN
[3] SAITAMA CANC CTR,RES INST,INA,SAITAMA 362,JAPAN
关键词
5-aza-2'-deoxycytidine; pancreatic cancer; cell cycle; Le(Y) antigen; apoptosis differentiation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effect of 5-aza-2'-deoxycytidine (ADC) (a specific inhibitor of DNA methylation) on differentiation, Lewis(y) (Le(y)) antigen expression, and DNA fragmentation (a biochemical marker of apoptosis) in human pancreatic cancer MIA PaCa-2 cells. ADC markedly inhibited the growth of MIA PaCa-2 cells. Flow cytometric analysis showed that ADC suppressed the cell population in the G(1) phase, but enhanced it in the G(2)/M phase. On the other hand, several markers of cell differentiation including morphological and biochemical alterations were distinctly induced in cells treated with ADC. Morphologically, the cells were enlarged and thinner than the untreated control cells, and intracellular alkaline phosphatase (ALP) activity was markedly increased. Additionally, biochemical markers of apoptosis including DNA fragmentation and Le(y) antigen expression were induced in association with the appearance of morphological and biochemical markers of differentiation (ALP). These results suggest that the hypomethylation of DNA is involved in the molecular mechanism of growth inhibition, induction of apoptosis, and differentiation in human pancreatic cancer MIA PaCa-2 cells.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 50 条
  • [21] 5-AZA-2′-DEOXYCYTIDINE IS A POTENTIAL INHIBITOR OF HUMAN PROSTATE CANCER INVASION
    Chen, Lin
    Zhang, Qiang
    Helfand, Brian
    Sharma, Vidit
    Qin, Weijun
    Brendler, Charles
    Zhu, Lihua
    Kundu, Shilajit D.
    Jiang, Thomas
    Zhang, Weipeng
    Lee, Bob
    Randall-London, Sherin
    Jovanovic, Borko
    Yang, Ximing J.
    Kozlowski, James
    Kuzel, Timothy Michael
    Guo, Yinglu
    Lee, Chung
    JOURNAL OF UROLOGY, 2011, 185 (04): : E168 - E168
  • [22] 5-aza-2′-deoxycytidine induces telomere dysfunction in breast cancer cells
    Al-dulaimi, Sarah
    Matta, Sheila
    Slijepcevic, Predrag
    Roberts, Terry
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [23] Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
    Qin, Taichun
    Jelinek, Jaroslav
    Si, Jiali
    Shu, Jingmin
    Issa, Jean-Pierre J.
    BLOOD, 2009, 113 (03) : 659 - 667
  • [24] 5-AZA-2'-DEOXYCYTIDINE - CELL-DIFFERENTIATION AND DNA METHYLATION
    TAYLOR, SM
    LEUKEMIA, 1993, 7 : 3 - 8
  • [25] The epigenetic modifiers 5-aza-2′-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells
    Zych, J.
    Stimamiglio, M. A.
    Senegaglia, A. C.
    Brofman, P. R. S.
    Dallagiovanna, B.
    Goldenberg, S.
    Correa, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (05) : 405 - 416
  • [26] Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine)
    Momparler, RL
    SEMINARS IN ONCOLOGY, 2005, 32 (05) : 443 - 451
  • [27] Delivery of 5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides
    Yoo, Christine B.
    Jeong, Shinwu
    Egger, Gerda
    Liang, Gangning
    Phiasivongsa, Pasit
    Tang, Chunlin
    Redkar, Sanjeev
    Jones, Peter A.
    CANCER RESEARCH, 2007, 67 (13) : 6400 - 6408
  • [28] Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness
    Sato, N
    Maehara, N
    Su, GH
    Goggins, M
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04): : 327 - 330
  • [29] Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
    Venturelli, Sascha
    Berger, Alexander
    Weiland, Timo
    Essmann, Frank
    Waibel, Michaela
    Nuebling, Tina
    Haecker, Sabine
    Schenk, Martin
    Schulze-Osthoff, Klaus
    Salih, Helmut R.
    Fulda, Simone
    Sipos, Bence
    Johnstone, Ricky W.
    Lauer, Ulrich M.
    Bitzer, Michael
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) : 2226 - 2236
  • [30] Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells
    Boivin, AJ
    Momparler, LF
    Hurtubise, A
    Momparler, RL
    ANTI-CANCER DRUGS, 2002, 13 (08) : 869 - 874